<DOC>
	<DOCNO>NCT00000711</DOCNO>
	<brief_summary>To administer colony-stimulating factor ( GM-CSF ) 4 week AIDS advance AIDS relate complex ( ARC ) patient receive zidovudine ( AZT ) therapy , order obtain data short-term effectiveness , safety , toxicity , pharmacokinetics , tolerance combine treatment two drug . Persons infect HIV virus may undergo long latency persistent virus blood level may present symptomatic illness . These individual could , therefore , benefit therapy effective antiretroviral agent . AZT , powerful inhibitor human retrovirus , approve management patient symptomatic HIV infection . GM-CSF stimulate bone marrow , enhance function mature blood cell find enhance ability AZT suppress HIV replication vitro ( test tube ) . Combination therapy GM-CSF AZT may lower complication well morbidity mortality associate HIV infection .</brief_summary>
	<brief_title>Granulocyte-Macrophage Colony-Stimulating Factor Zidovudine : A Phase I Study Concurrent Administration Patients With AIDS Severe ARC</brief_title>
	<detailed_description>Persons infect HIV virus may undergo long latency persistent virus blood level may present symptomatic illness . These individual could , therefore , benefit therapy effective antiretroviral agent . AZT , powerful inhibitor human retrovirus , approve management patient symptomatic HIV infection . GM-CSF stimulate bone marrow , enhance function mature blood cell find enhance ability AZT suppress HIV replication vitro ( test tube ) . Combination therapy GM-CSF AZT may lower complication well morbidity mortality associate HIV infection . Colony stimulate factor ( GM-CSF ) administer subcutaneously , day every day , 4 week AIDS advance ARC patient receive continue receive constant dose AZT . Treatment outpatient basis .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Zidovudine</mesh_term>
	<criteria>Inclusion Criteria Concurrent Medication : Allowed : Modest dos acetaminophen , aspirin , nonprescription dos ibuprofen may use caution fever control mild analgesia . Prolonged use 72 hour advise without dose supervision . All patient document history positive HIV antibody ELISA test . Patients qualify zidovudine ( AZT ) treatment follow reason : Patients prior episode cytologically confirm Pneumocystis carinii pneumonia ( PCP ) . Patients prior episode AIDSdefining opportunistic infection le 200 T4 cell . Patients advance ARC define mucocutaneous candidiasis and/or unexplained weight loss le 200 T4 cell fever 100 degree F 3 week duration ; clinical diagnosis hairy leukoplakia ; herpes zoster infection within 3 month entry ; unexplained diarrhea . All patient must receive least 8 week AZT prior enrollment must require dose adjustment previous 4 week . Patients must willing sign inform consent statement . Required : Zidovudine ( AZT ) least 8 week . Exclusion Criteria Coexisting Condition : The following patient exclude : Patients receive zidovudine ( AZT ) enrol another protocol . Patients lifethreatening uncontrolled opportunistic infection . Patients evidence lymphoma neoplasm indolent Kaposi 's sarcoma . Dementia would prevent give appropriate informed consent . Concurrent Medication : Excluded : Acetaminophen product contain acetaminophen . Drugs nephrotoxic , cytotoxic , decrease blood cell number function may increase risk toxicity . Probenecid may inhibit excretion zidovudine ( AZT ) . Some experimental nucleoside analog avoid . The following patient exclude : Patients receive zidovudine ( AZT ) enrol another protocol . Patients lifethreatening uncontrolled opportunistic infection . Patients evidence lymphoma neoplasm indolent Kaposi 's sarcoma . Dementia would prevent give appropriate informed consent . Prior Medication : Excluded within 8 week study entry : Prior systemic therapy antimetabolite , cytotoxic drug , interferon , immunomodulator , corticosteroid , nucleoside analog zidovudine .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Neutropenia</keyword>
	<keyword>Drug Evaluation</keyword>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>Granulocyte-Macrophage Colony-Stimulating Factor</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>AIDS-Related Complex</keyword>
	<keyword>Zidovudine</keyword>
</DOC>